Annual report pursuant to Section 13 and 15(d)

Stock-based Compensation (Tables)

v3.8.0.1
Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of fair value of options granted
    December 31,   December 31,
    2017   2016
Expected life (in years)   6.5 years   6.5 years
Risk-free interest rate   1.86% – 2.00%   1.13% - 1.24%
Volatility   37%   37%
Dividend yield   0%   0%
Schedule of stock option activity
     Shares    

Weighted

Average

Exercise

 Price

   

Weighted

Average

Remaining

Contractual

 Life (Years)

   

 Intrinsic

Value

 
Outstanding at December 31, 2016     1,857,012       4.28                  
2017 Grants     1,260,000       1.96                  
Exercised                            
Cancelled, expired or forfeited     (801,977 )     3.14                  
Outstanding at December 31, 2017     2,315,035       3.41       7.25     $ 497,700  
Exercisable at December 31, 2017     890,384       4.84       4.67        
Schedule of non-vested stock options
     Shares    

Weighted

Average

Grant Date

Fair Value

 
Non-vested shares at December 31, 2016     1,180,030     $ 1.56  
Granted     1,260,000       0.79  
Vested     (245,402 )     1.76  
Forfeited     (769,977 )     1.28  
Non-vested shares at December 31, 2017     1,424,651     $ 0.99  
Schedule of restricted stock awards and changes
    Shares     Weighted Average
Grant Date Fair 
Value
 
             
Non-vested at December 31, 2016     716,250     $ 2.73  
Granted     710,000       1.83  
Vested     (181,750 )     2.01  
Cancelled, expired or forfeited     (259,500 )     2.56  
Non-vested at December 31, 2017     985,000     $ 2.26